Predict your next investment

Corporation
HEALTHCARE | Biotechnology
thermofisher.com

See what CB Insights has to offer

Investments

5

Portfolio Exits

7

Partners & Customers

10

About Thermo Fisher Scientific

Thermo Fisher Scientific provides a broad range of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics applications. Clients include pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies. The company's portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, fine and high-purity chemistry production, cell culture, RNA interference analysis, and immunodiagnostic testing.

Thermo Fisher Scientific Headquarter Location

168 Third Avenue

Waltham, Massachusetts, 02451,

United States

781 622 1000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Thermo Fisher Scientific

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Thermo Fisher Scientific in 4 Expert Collections, including Fortune 500 Investor list.

F

Fortune 500 Investor list

590 items

This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.

C

Cancer

105 items

Products/services that analyze tumor-derived biomarkers (ctDNA, CTCs, exosomes) in blood/urine/other non-invasive liquid specimens to detect cancer earlier, guide treatment, and monitor progress. *Data fields manually updated as new information becomes available.'

M

Medical Devices

3,468 items

https://mdic.org/membership/our-members/

H

Health Monitoring & Diagnostics

76 items

Companies developing companion diagnostics and technology enabling the development of companion diagnostics. Tagged as #CompanionDx

Thermo Fisher Scientific Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Thermo Fisher Scientific Rank

Research containing Thermo Fisher Scientific

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Thermo Fisher Scientific in 1 CB Insights research brief, most recently on Mar 4, 2020.

Latest Thermo Fisher Scientific News

HeLa cells controversy: Court poised to consider whether Henrietta Lacks’ family lawsuit claiming her cells were stolen 70 years ago can continue

May 26, 2022

Lawrence Lacks, center, son of Henrietta Lacks, raises his arm, along with attorney Ben Crump, right, as members of the Lacks family and their attorneys hold a news conference after their appearance this morning in federal court. Alfred Lacks-Carter, grandson of Henrietta Lacks, is on left. May 17, 2022. Credit: Barbara Haddock Taylor/Baltimore Sun This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation. It is posted under Fair Use guidelines . A federal judge will decide whether the family of Henrietta Lacks has enough legal standing to continue their lawsuit against the biotech company Thermo Fisher Scientific after the two sides argued in court [May 17] about the use of cells taken from Lacks over 70 years ago. At question is whether Thermo Fisher — and other companies — ought to compensate Lacks’ living descendants for products derived from cervical cancer cells taken without her consent while she was receiving treatment at Johns Hopkins in 1951. Lacks, a Black woman from Baltimore County, died soon after the cells were taken due to complications from the cancer treatment she received. Known as HeLa cells, they have been used since for a variety of scientific and medical breakthroughs and treatments. Researchers in the early 1950s used them to develop the polio vaccine, and they were instrumental in mapping the human genome. Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter. Attorneys Ben Crump and Christopher Seeger argued in court that the lawsuit should be allowed to continue because of the continual harm being done against the Lacks family, comparing it to German families who held onto money taken from Holocaust victims. “They stole pieces of her body; they shouldn’t be allowed to benefit, to copyright those cells, to create new cell lines without even one phone call [to the Lacks family],” Seeger said. Mother of five, Henrietta Lacks died in 1951 at the age of 31. Credit: Courtesy of the Lacks family

Thermo Fisher Scientific Investments

5 Investments

Thermo Fisher Scientific has made 5 investments. Their latest investment was in Ionpath as part of their Corporate Minority on May 5, 2022.

CBI Logo

Thermo Fisher Scientific Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/11/2022

Corporate Minority

Ionpath

Yes

2

2/24/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

10/30/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/19/2019

Corporate Minority

Subscribe to see more

Subscribe to see more

10

3/11/2004

Series A

Subscribe to see more

$99M

Subscribe to see more

0

Date

5/11/2022

2/24/2021

10/30/2019

2/19/2019

3/11/2004

Round

Corporate Minority

Series B

Series A

Corporate Minority

Series A

Company

Ionpath

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

10

0

Thermo Fisher Scientific Portfolio Exits

7 Portfolio Exits

Thermo Fisher Scientific has 7 portfolio exits. Their latest portfolio exit was Arranta Bio on February 18, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/18/2022

Acquired

3

6/29/2019

Divestiture

Subscribe to see more

Subscribe to see more

10

1/28/2019

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

7/19/2017

Acquired - III

Subscribe to see more

$99M

Subscribe to see more

10

8/30/2013

Acquired - II

Subscribe to see more

Subscribe to see more

10

Date

2/18/2022

6/29/2019

1/28/2019

7/19/2017

8/30/2013

Exit

Acquired

Divestiture

Divestiture

Acquired - III

Acquired - II

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

Thermo Fisher Scientific Acquisitions

44 Acquisitions

Thermo Fisher Scientific acquired 44 companies. Their latest acquisition was PeproTech on January 05, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/5/2022

$99M

Acquired

8

12/8/2021

Other

$99M

$71.05M

Acq - P2P

16

11/1/2021

Series B

$99M

$12.38M

Acquired

4

10/4/2021

Series A

Subscribe to see more

$99M

$99M

Subscribe to see more

10

2/17/2021

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/5/2022

12/8/2021

11/1/2021

10/4/2021

2/17/2021

Investment Stage

Other

Series B

Series A

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$71.05M

$12.38M

$99M

Note

Acquired

Acq - P2P

Acquired

Subscribe to see more

Subscribe to see more

Sources

8

16

4

10

10

Thermo Fisher Scientific Partners & Customers

10 Partners and customers

Thermo Fisher Scientific has 10 strategic partners and customers. Thermo Fisher Scientific recently partnered with Multiply Labs on May 5, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

5/5/2022

Partner

United States

Multiply Labs Adds Thermo Fisher Scientific and Charles River Laboratories to Its Robotic Manufacturing Consortium

As a founding member of the Consortium , Cytiva is collaborating with Multiply Labs to automate the operation of the Xuri bioreactors , with the goal of enabling robots to manage the process and reduce manual touchpoints .

2

4/19/2022

Partner

Thermo Fisher Scientific Enhances Clinical Research Solutions in Collaboration with Matrix Clinical Trials

Tim Rich , vice president , digital and decentralized solutions , clinical research , Thermo Fisher Scientific Inc. , comments on the collaboration with Matrix Medical Network Clinical Trials to bring clinical trials to patients with an innovative decentralized clinical trial solution .

1

4/14/2022

Partner

United States

Moderna and Thermo Fisher Scientific Honored for COVID-19 Vaccine Efforts

As Moderna 's clinical research organization partner , the PPD team , now part of Thermo Fisher Scientific Inc. , supported Moderna 's mRNA-1273-P301 vaccine trials , including its pivotal Phase III COVE study .

2

3/2/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

2/23/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

5/5/2022

4/19/2022

4/14/2022

3/2/2022

2/23/2022

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Country

United States

United States

United States

United States

News Snippet

Multiply Labs Adds Thermo Fisher Scientific and Charles River Laboratories to Its Robotic Manufacturing Consortium

As a founding member of the Consortium , Cytiva is collaborating with Multiply Labs to automate the operation of the Xuri bioreactors , with the goal of enabling robots to manage the process and reduce manual touchpoints .

Thermo Fisher Scientific Enhances Clinical Research Solutions in Collaboration with Matrix Clinical Trials

Tim Rich , vice president , digital and decentralized solutions , clinical research , Thermo Fisher Scientific Inc. , comments on the collaboration with Matrix Medical Network Clinical Trials to bring clinical trials to patients with an innovative decentralized clinical trial solution .

Moderna and Thermo Fisher Scientific Honored for COVID-19 Vaccine Efforts

As Moderna 's clinical research organization partner , the PPD team , now part of Thermo Fisher Scientific Inc. , supported Moderna 's mRNA-1273-P301 vaccine trials , including its pivotal Phase III COVE study .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

2

10

10

Thermo Fisher Scientific Team

64 Team Members

Thermo Fisher Scientific has 64 team members, including current Chief Executive Officer, President, Marc Casper.

Name

Work History

Title

Status

Marc Casper

Chief Executive Officer, President

Current

Daniella Cramp

President, Senior Vice President

Current

Greg Herrema

President, Senior Vice President

Current

Syed Jafry

President, Senior Vice President

Current

David Johnston

President, Senior Vice President

Current

Name

Marc Casper

Daniella Cramp

Greg Herrema

Syed Jafry

David Johnston

Work History

Title

Chief Executive Officer, President

President, Senior Vice President

President, Senior Vice President

President, Senior Vice President

President, Senior Vice President

Status

Current

Current

Current

Current

Current

You May Also Like

S
Smiths Detection Group

Threat detection equipment from Smiths Detectionis used forx-ray screening, baggage screening & CBRNE detection and is used by emergency responders and airport security officers.

Sapient Industries Logo
Sapient Industries

Sapient Industries develops an autonomous energy management system that senses and learns human behavior in order to eliminate wasted energy in buildings.

LECO Logo
LECO

LECO is a provider of analytical solutions for a variety of applications and markets.

Rigaku Logo
Rigaku

Rigaku is a global scientific analytical instrumentation company specializing in X-ray analysis, thermal analysis, and non-destructive testing. The company focuses on developing and supplying universities, industry, and government labs with customer-focused integrated solutions across a wide variety of disciplines, including structural proteomics, nanoengineering research, general purpose X-ray diffraction (XRD) and spectroscopy (XRF), materials analysis, and quality assurance.

WattIQ Logo
WattIQ

WattIQ aims to solve the problem of wasted energy from electrical devices that consume power even when not in use. The company applies machine learning to power consumption at the device level, analyzing assets like centrifuges, incubators, HPLCs, vending machines, freezers, and other electrical office equipment as soon as they connect to the smart plugs.

Molsid Logo
Molsid

Molsid develops and commercializes molecular probes with retention of the fluorescent signal which brings numerous advantages to the industrialists of various sectors because they make visible what the conventional probes do not make it possible to visualize. The "SmartID" technology allows a fast, stable and reliable detection of enzymatic activity in a biological sample, in vitro and in vivo, thanks to a retention unique fluorescent signal.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.